Biomedical Engineering Reference
In-Depth Information
215. Boado, R. J.; Zhang, Y.; Pardridge, W. M. Humanization of Anti-human Insulin Receptor Anti-
body for Drug Targeting across the Human Blood-Brain Barrier.
Biotechnol. Bioeng.
2007,
96,
381-391.
216. Ulbrich, K.; Hekmatara, T.; Herbert, E.; Kreuter, J. Transferrin- and Transferrin Receptor-
Antibody-Modified Nanoparticles Enable Drug Delivery across the Blood-Brain Barrier (BBB).
Eur. J. Pharm. Biopharm.
2009,
71,
251-256.
217. Chen, X.; Schluesener, H. J. Nanosilver: A Nanoproduct in Medical Application.
Toxicol. Lett.
2008,
176,
1-12.
218. Tian, F.; Cui, D.; Schwarz, H.; Estrada, G.; Kobayashic, H. Cytotoxicity of Single Wall Car-
bon Nanotubes on Human Fibroblasts.
Toxicol. In Vitro
2006,
20,
1202-1212.
219. Beyerle, A.; Merkel, O.; Stoeger, T.; Kissel, T. PEGylation Affects Cytotoxicity and Cell-
Compatibility of Poly(ethylene imine) for Lung Application: Structure Function Relation-
ships.
Toxicol. Appl. Pharmacol.
2010,
242,
146-154.
220. Hagens, W. I.; Oomen, A. G.; de Jong, W. H.; Cassee, F. R.; Sips, A. What Do We (need to)
KnowabouttheKineticPropertiesofNanoparticlesintheBody?
Regul.Toxicol.Pharmacol.
2007,
49,
217-229.
221. Kreyling, W. G.; Möller, W.; Semmler-Behnke, M.; Oberdörster, G. Particle Toxicology.
In Born, D. K., Ed.; CRC Press: Boca Raton, FL, 2007.
222. Kreyling, W. G.; Geiser, M. Dosimetry of Inhaled Nanoparticles. In:
Inhalation and Health
Effects
; Marijnissen, J. C., Ed.; Springer: Berlin, 2009.
223. Desai, M. P.; Labhasetwar, V.; Walter, E.; Levy, R. J.; Amidon, G. L. The mechanism of uptake
of biodegradable microparticles in Caco-2 cells is size dependent.
Pharm. Res.
1997,
14,
1568-1573.
